US 11685906
Compositions and methods for treating ornithine transcarbamylase deficiency
granted A61KA61K48/00A61P
Quick answer
US patent 11685906 (Compositions and methods for treating ornithine transcarbamylase deficiency) held by ARCTURUS THERAPEUTICS, INC. expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K48/00, A61P, A61P9/00